11-5226761-T-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_000518.5(HBB):āc.131A>Cā(p.Glu44Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E44Q) has been classified as Likely benign.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.131A>C | p.Glu44Ala | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.131A>C | p.Glu44Ala | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994.3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152048Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74266
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jun 30, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 18, 2019 | The Hb G-Galveston variant (HBB: c.131A>C; p.Glu44Ala, also known as Glu43Ala when numbered from the mature protein; rs35262412) has not been reported in association with clinical symptoms, either in a homozygous state or when found with other pathogenic beta globin variants (Edington 1955, McCurdy 1974, Michlitsch 2009, HbVar and references therein). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), but it is reported in ClinVar (Variation ID: 15173). The glutamate at codon 44 is weakly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Based on available information, the Hb G-Galveston variant is considered likely benign. References: Link to HbVar for Hb G-Galveston: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=317 Edington G et al. Characterization and genetics of haemoglobin G. Nature. 1955; 175(4463):850-1. McCurdy P et al. Hemoglobin S-G (S-D) syndrome. Am J Med. 1974; 57(4):665-70. Michlitsch J et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009; 52(4):486-90. - |
HEMOGLOBIN G (PORT ARTHUR) Other:1
other, no assertion criteria provided | literature only | OMIM | Jul 20, 2016 | - - |
HEMOGLOBIN G (GALVESTON) Other:1
other, no assertion criteria provided | literature only | OMIM | Jul 20, 2016 | - - |
HEMOGLOBIN G (TEXAS) Other:1
other, no assertion criteria provided | literature only | OMIM | Jul 20, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at